| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.004 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |